BRAIN TUMOR, RECURRENT
Clinical trials for BRAIN TUMOR, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, RECURRENT trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain tumor drug delivered via pump shows promise in early trial
Disease control Recruiting nowThis early-phase study tests the safety of delivering the chemotherapy drug topotecan directly to the brain using a pump and catheter system (convection-enhanced delivery) in 6 people with a recurrent, aggressive type of brain tumor called IDH-mutant malignant glioma. The treatme…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE1 • Sponsor: Jeffrey N. Bruce • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Cannabis spray could boost chemo for deadly brain tumors
Disease control Recruiting nowThis phase II trial tests whether adding a cannabis-based mouth spray (nabiximols) to standard chemotherapy helps people with recurrent glioblastoma live longer. About 120 adults whose brain tumor has returned after initial treatment will receive either the cannabis spray or a pl…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo attack on recurrent brain tumors shows promise in early trial
Disease control Recruiting nowThis phase 2 trial tests a new way to deliver the cancer drug cetuximab directly into the brain's arteries, along with mannitol to open the blood-brain barrier, plus targeted radiation. It is for adults with recurrent glioblastoma or other aggressive brain tumors that have high l…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Sound waves could boost brain cancer drug delivery
Disease control Recruiting nowThis Phase 3 trial tests whether combining the drug Avastin with a focused ultrasound system (NaviFUS) can improve outcomes for people with recurrent glioblastoma, an aggressive brain cancer. The ultrasound temporarily opens the blood-brain barrier to let more drug reach the tumo…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New Tile-Shaped radiation device tested for brain tumors
Disease control Recruiting nowThis study is tracking 600 people with brain tumors who receive GammaTile therapy during surgery. GammaTile is a device that delivers radiation directly to the tumor site to help prevent regrowth. Researchers are measuring how long tumors stay under control and how patients feel …
Matched conditions: BRAIN TUMOR, RECURRENT
Sponsor: GT Medical Technologies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC